RAUDIXIN Drug Patent Profile
✉ Email this page to a colleague
When do Raudixin patents expire, and when can generic versions of Raudixin launch?
Raudixin is a drug marketed by Apothecon and is included in one NDA.
The generic ingredient in RAUDIXIN is rauwolfia serpentina root. There are eight drug master file entries for this compound. Additional details are available on the rauwolfia serpentina root profile page.
Summary for RAUDIXIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 101 |
Patent Applications: | 1,231 |
Formulation / Manufacturing: | see details |
DailyMed Link: | RAUDIXIN at DailyMed |
US Patents and Regulatory Information for RAUDIXIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apothecon | RAUDIXIN | rauwolfia serpentina root | TABLET;ORAL | 008842-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apothecon | RAUDIXIN | rauwolfia serpentina root | TABLET;ORAL | 008842-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |